Deep phlebothrombosis in pregnancy, first trimester
ICD-10 O22.31 is a billable code used to indicate a diagnosis of deep phlebothrombosis in pregnancy, first trimester.
Deep phlebothrombosis (DVT) in pregnancy, particularly during the first trimester, is a serious condition characterized by the formation of a blood clot in the deep veins, most commonly in the legs. This condition poses significant risks to both the mother and fetus, including potential complications such as pulmonary embolism, which can be life-threatening. The incidence of DVT is increased during pregnancy due to physiological changes such as increased blood volume, hormonal changes that promote coagulation, and venous stasis caused by the growing uterus. Early diagnosis and management are crucial, often involving imaging studies like Doppler ultrasound and the use of anticoagulants to prevent clot progression and complications. Careful monitoring and follow-up are essential to ensure maternal and fetal safety, particularly in the context of anticoagulation therapy, which requires balancing the risks of thrombosis against the risks of bleeding. Coders must ensure accurate documentation of the condition, treatment plans, and any associated complications to facilitate appropriate coding and billing.
Documentation must include details of the diagnosis, treatment plan, and any imaging studies performed.
A pregnant patient presents with leg swelling and pain; Doppler ultrasound confirms DVT.
Consideration of anticoagulation risks and benefits, especially in the first trimester.
Detailed documentation of maternal and fetal monitoring, especially in high-risk cases.
A patient with a history of DVT presents for management during pregnancy.
Focus on high-risk factors and the need for multidisciplinary care.
Used to confirm DVT diagnosis in a pregnant patient presenting with leg symptoms.
Document the indication for the ultrasound and findings.
Ensure that the ultrasound is performed by a qualified provider and interpreted correctly.
Common symptoms include unilateral leg swelling, pain, tenderness, and warmth in the affected leg. Some patients may also experience changes in skin color.
